Association of metformin exposure with low risks of frailty and adverse outcomes in patients with diabetes
Abstract Background Diabetes is an independent risk factor of frailty, which increases adverse outcomes in patients with diabetes. Metformin is a common antidiabetic drug in clinical practice. Insulin resistance and chronic inflammation are the two common mechanisms of diabetes and frailty, as well...
Main Authors: | Pan Liu, Yiming Pan, Yu Song, Yaru Zhou, Wanshu Zhang, Xiaojun Li, Jiatong Li, Yun Li, Lina Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-023-01017-6 |
Similar Items
-
Frailty as a predictor of short-term adverse outcomes
by: Tiago Coelho, et al.
Published: (2015-07-01) -
Preoperative Frailty and Postoperative Adverse Outcomes among Elderly Patients with Gastric Cancer
by: MIAO Xueyi, DING Lingyu, LU Jinling, HU Jieman, ZHU Hanfei, CHEN Li, XU Xinyi, XU Qin
Published: (2023-03-01) -
Impact of frailty, mild cognitive impairment and cognitive frailty on adverse health outcomes among community-dwelling older adults: A systematic review and meta-analysis
by: Baoyu Chen, et al.
Published: (2022-10-01) -
Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice
by: Edward Fielder, et al.
Published: (2022-05-01) -
Research on the frailty status and adverse outcomes of elderly patients with multimorbidity
by: Jing Lv, et al.
Published: (2022-07-01)